Trials / Completed
CompletedNCT00131287
The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 108 (planned)
- Sponsor
- ECbiotech Taiwan · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to examine whether the extract of the Agaricus blazei Murill mushroom is effective in the supplementary treatment of type II DM patients.
Detailed description
The researchers have the animal model that the extract of the Agaricus blazei Murill mushroom is effective in the treatment of type II DM mice conducted on 2002. The dose effects were also found. The researchers conducted the pilot study also showing the same effects in 2003. So the researchers designed this trial. The elixir of the Agaricus blazei Murill mushroom is popular in Taiwan for chronic diseases, such as type II DM.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Extract of Agaricus blazei Murill |
Timeline
- Start date
- 2005-07-01
- Completion
- 2006-12-01
- First posted
- 2005-08-18
- Last updated
- 2010-01-05
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00131287. Inclusion in this directory is not an endorsement.